Evidence map›Paper›PMID 42572842›Full record

ReviewJournal of cell science2026

Alterations of actin in aging.

Maxim Averbukh, Tiffany Wang, Gilberto Garcia, Ryo Higuchi-Sanabria

Abstract readReview
In one paragraph

Review in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maxim AverbukhLeonard Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.
Tiffany WangLeonard Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.
Gilberto GarciaLeonard Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.
Ryo Higuchi-SanabriaLeonard Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.ORCID 0000-0001-8936-5812

Funding

USC Geroscience Training in the Biology of AgingT32AG052374 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Sean P CURRAN · 2016 to 2026
$5.3M
When actin’s not actin like actin: Nuclear actin impacts transcription and agingR01AG079806 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Ryo Higuchi-Sanabria · 2024 to 2026
$1.9M
More than just a load control: cytoskeletal form and function during agingR00AG065200 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HIGUCHI-SANABRIA, RYO · 2021 to 2023
$747k
California Institute of Regenerative MedicineNIA NIH HHS R00 AG065200NIA NIH HHS R01 AG079806NIA NIH HHS R01AG079806NIA NIH HHS R01AG079806-02S1NIA NIH HHS T32 AG052374NIA NIH HHS T32AG052374
6 · The paper itself

Abstract

The actin cytoskeleton is a highly dynamic and evolutionarily conserved multi-protein complex that regulates cellular architecture, mechanics and intracellular organization. Although actin dynamics and organization have been extensively studied in development and some disease contexts, the role of the actin cytoskeleton in aging has only recently begun to be considered. Accumulating evidence across model organisms indicates that aging is accompanied by progressive actin disorganization, which can manifest as filament disassembly, aggregation and mislocalization, impacting cellular homeostasis. In this Review, we synthesize the current understanding of how actin integrity is maintained through chaperone networks, actin-binding proteins, transcriptional programs and post-translational modifications, and how these regulatory layers change during the aging process. We then describe how these changes emerge as links between cytoskeletal decline and core aging hallmarks, including loss of proteostasis, mitochondrial dysfunction and cellular senescence. We further examine how this actin-related cellular dysregulation contributes to age-associated diseases, including neurodegeneration, cancer and muscle degeneration. Finally, we highlight recent studies suggesting that targeted modulation of actin regulatory pathways might preserve cellular resilience and healthspan, while emphasizing the challenges and opportunities in therapeutically targeting such a fundamental cellular system.

Indexed as

Actin CytoskeletonActinsAgingAnimalsCellular SenescenceHumansProtein Processing, Post-TranslationalActinsActinAgingCancerNeurodegeneration

Identifiers

PMID42572842
PMCPMC13481056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.